Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899140-08-001307
Filing Date
2008-06-10
Accepted
2008-06-10 16:38:25
Documents
2
Period of Report
2007-11-09

Document Format Files

Seq Description Document Type Size
1 oimi_accp3-061008ex.html 3  
1 oimi_accp3-061008ex.xml 3 5140
2 EXHIBIT 99.1 EXPLANATION OF RESPONSES o4183189.txt EX-99 2415
  Complete submission text file 0000899140-08-001307.txt   9673
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 GREENWICH AVE 3RD FL GREENWICH CT 06830
Business Address 200 GREENWICH AVE 3RD FL GREENWICH CT 06830 2126886262
ORACLE INVESTMENT MANAGEMENT INC (Reporting) CIK: 0001012622 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 08891176